Nihon Kohden (OTCMKTS:NHNKY) Reaches New 12-Month Low – Here’s What Happened

Nihon Kohden Corporation (OTCMKTS:NHNKY)’s stock price reached a new 52-week low during trading on Monday . The company traded as low as $8.1225 and last traded at $8.1225, with a volume of 1158 shares trading hands. The stock had previously closed at $8.48.

Analyst Ratings Changes

Separately, Zacks Research raised Nihon Kohden to a “hold” rating in a report on Monday, April 27th. One research analyst has rated the stock with a Strong Buy rating and one has given a Hold rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Buy”.

Nihon Kohden Stock Down 2.4%

The firm has a market cap of $1.41 billion, a PE ratio of 14.03 and a beta of 0.40. The firm has a 50-day moving average price of $9.26 and a two-hundred day moving average price of $10.18.

Nihon Kohden (OTCMKTS:NHNKY) last released its earnings results on Thursday, May 14th. The company reported $0.34 earnings per share for the quarter, beating the consensus estimate of $0.24 by $0.10. Nihon Kohden had a return on equity of 9.48% and a net margin of 6.08%.The business had revenue of $453.10 million for the quarter, compared to the consensus estimate of $414.40 million. Research analysts forecast that Nihon Kohden Corporation will post 0.61 earnings per share for the current fiscal year.

About Nihon Kohden

Nihon Kohden Corporation is a Tokyo-based manufacturer of medical electronic equipment, founded in 1951. The company has built a reputation for innovation in patient monitoring and diagnostic systems, developing one of Japan’s earliest electrocardiogram (ECG) machines and pioneering transistor-based oscilloscopes for clinical use. Over the decades, Nihon Kohden has expanded its product portfolio to address a wide range of healthcare needs, from emergency response to intensive care and neurology.

The company’s core offerings include patient monitors, ECG and electroencephalograph (EEG) devices, defibrillators, infusion pumps, and neuromonitoring systems.